BAILARD, INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$2,749,000
-5.1%
81,900
-20.3%
0.16%
-11.4%
Q3 2019$2,897,000
-13.8%
102,800
-18.9%
0.18%
-14.6%
Q2 2019$3,360,000
+10.6%
126,800
-23.4%
0.20%
+9.0%
Q1 2019$3,039,000
+122.5%
165,600
+50.5%
0.19%
+104.3%
Q4 2018$1,366,000
+103.6%
110,000
+214.3%
0.09%
+135.9%
Q3 2018$671,00035,0000.04%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders